EP2914248
Lyfjasamsetningar til meðhöndlunar á CFTR-miðluðum sjúkdómum
Status:
EP einkaleyfi: Endurútgefin þýðing EP einkaleyfisEP appl. date:
1.11.2013EP published:
5.9.2018EP application number:
13792149.0
EP translation filed:
15.10.2018Grant published:
15.11.2018EPO information:
European Patent Register
Max expiry date:
31.10.2033Expiry date:
31.10.2026Next due date:
30.11.2026
Title:
PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CFTR MEDIATED DISEASES
Timeline
Today
1.11.2013EP application
5.9.2018EP Publication
15.10.2018Translation submitted
15.11.2018Registration published
31.10.2026Expires
Owner
Name:
Vertex Pharmaceuticals IncorporatedAddress:
50 Northern Avenue, 02210, Boston, MA, US
Inventor
Name:
VERWIJS, Marinus, JacobusAddress:
Framingham, MA, US
Name:
KARKARE, RadhikaAddress:
Medford, MA, US
Name:
MOORE, Michael, DouglasAddress:
Charlestown, MA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201261721622 PDate:
2.11.2012Country:
US
Number:
201261728328 PDate:
20.11.2012Country:
US
Number:
201361770668 PDate:
28.2.2013Country:
US
Number:
201361824005 PDate:
16.5.2013Country:
US
Number:
201361840668 PDate:
28.6.2013Country:
US
Classification
Categories:
A61K 9/20, A61K 45/06, A61K 31/443, A61K 31/47
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 5.10.2018
Expires: 31.10.2019
Payer: Árnason Faktor
Number: 7
Paid: 18.10.2019
Expires: 31.10.2020
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 20.10.2020
Expires: 31.10.2021
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 19.10.2021
Expires: 31.10.2022
Payer: Sigurjónsson & Thor ehf.
Number: 10
Paid: 18.10.2022
Expires: 31.10.2023
Payer: Patice ehf.
Number: 11
Paid: 25.10.2023
Expires: 31.10.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 22.10.2024
Expires: 31.10.2025
Payer: Árnason Faktor ehf.
Number: 13
Paid: 4.11.2025
Expires: 31.10.2026
Payer: Árnason Faktor ehf.